v3.26.1
Commitments and Contingencies - Additional Information (Details)
€ in Thousands
 1 Months Ended 3 Months Ended
May 16, 2022
USD ($)
Mar. 31, 2026
USD ($)
OperatingLease
Sep. 30, 2024
USD ($)
Sep. 30, 2022
USD ($)
Jan. 31, 2022
USD ($)
Jul. 31, 2019
USD ($)
Dec. 31, 2014
USD ($)
LicensedProduct
Jan. 31, 2014
USD ($)
Sep. 30, 2013
USD ($)
Jul. 31, 2011
USD ($)
Nov. 30, 2009
EUR (€)
Mar. 31, 2026
USD ($)
OperatingLease
Mar. 31, 2025
USD ($)
Lessee Lease Description [Line Items]                          
Estimated payments due   $ 23,506,000                   $ 23,506,000  
Research and development expenses                       27,960,000 $ 23,343,000
National Institute of Health                          
Lessee Lease Description [Line Items]                          
License issue royalty fee                 $ 100,000        
Sales milestone payments                 600,000        
Development and regulatory milestone payments                 $ 700,000        
Patent licensing reimbursement fees                       30,000.00  
Expenses for patent licensing fees                       0 0
Royalty Bearing Patent License Agreement                          
Lessee Lease Description [Line Items]                          
Expenses                       0 0
License agreement term                     10 years    
Royalty Bearing Patent License Agreement | IND Filings                          
Lessee Lease Description [Line Items]                          
Potential milestone payments | €                     € 10    
Clearside                          
Lessee Lease Description [Line Items]                          
Expenses                       1,000,000 0
Upfront payment   1,000,000       $ 100,000              
One-time Payment   $ 1,500,000                      
Royalties on net sales           20.00%              
License agreement expiration period           10 years              
Clearside | Maximum                          
Lessee Lease Description [Line Items]                          
Aggregate milestones payment           $ 21,000,000              
LI-COR, Inc. | 2014 Exclusive Agreement                          
Lessee Lease Description [Line Items]                          
One-time upfront license issuance fee               $ 100,000          
Research and development expenses                       0 0
License agreement expiration period               10 years          
LI-COR, Inc. | 2014 Exclusive Agreement | Maximum                          
Lessee Lease Description [Line Items]                          
Aggregate milestone payments               $ 200,000          
LI-COR, Inc. | 2014 Non- Exclusive Agreement                          
Lessee Lease Description [Line Items]                          
License issue fee             $ 30,000.00            
Milestone payments                       0 0
LI-COR, Inc. | 2014 Non- Exclusive Agreement | Maximum                          
Lessee Lease Description [Line Items]                          
Payments for development and commercial milestones             $ 400,000            
Life Technologies                          
Lessee Lease Description [Line Items]                          
Milestone payments                       0 0
Number of licensed products | LicensedProduct             5            
Initial license fee             $ 100,000            
Initial license fee for first licensed product       $ 400,000                  
Initial license fee for additional licensed product       500,000                  
Payment for sublicense       200,000                  
Payment for use of cell line document package       30,000.00                  
Annual development fee             100,000            
Non-refundable, Non- creditable fee             300,000            
Change of control fees       $ 500,000     200,000            
One time perpetual license agreement fee         $ 50,000.00                
Expense related to agreement including sublicense                       0 0
Dr. John Schiller | 2014 Non- Exclusive Agreement                          
Lessee Lease Description [Line Items]                          
Required amendment payment     $ 60,000.00                    
Required amendment payment due period     30 days                    
Dr. John Schiller | Collaboration Research and Development Agreement                          
Lessee Lease Description [Line Items]                          
Annual development fee                   $ 30,000.00      
Agreement term                   2 years      
First payment due                   30 days      
Subsequent payments due                   30 days      
Research collaboration fees                       0 0
Dr. John Schiller | Collaboration Research and Development Agreement | 10th Anniversary                          
Lessee Lease Description [Line Items]                          
Required amendment payment     $ 50,000.00                    
Required amendment payment due period     30 days                    
Dr. John Schiller | Collaboration Research and Development Agreement | Ninth Amendment                          
Lessee Lease Description [Line Items]                          
Expenses                       $ 0 $ 0
Rakuten | 2014 Non- Exclusive Agreement                          
Lessee Lease Description [Line Items]                          
License issue fee             30,000.00            
Rakuten | 2014 Non- Exclusive Agreement | Maximum                          
Lessee Lease Description [Line Items]                          
License issue fee             $ 300,000            
Office and Laboratory Facility                          
Lessee Lease Description [Line Items]                          
Number of operating lease | OperatingLease   1                   1  
Estimated payments due $ 35,200,000                        
Lease commencement date Aug. 01, 2022                        
Operating lease, option to extend term 7 years                        
Letters of credit $ 800,000